BioXcel Therapeutics, Inc. (BTAI)
0.0739
-0.04
(-37.11%)
USD |
NASDAQ |
Sep 04, 16:00
0.0434
-0.03
(-41.27%)
After-Hours: 20:00
BioXcel Therapeutics Price to Book Value
Price to Book Value Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Price to Book Value Data
| Date | Value |
|---|---|
| September 29, 2023 | 202.04 |
| September 28, 2023 | 198.84 |
| September 27, 2023 | 218.81 |
| September 26, 2023 | 220.40 |
| September 25, 2023 | 226.79 |
| September 22, 2023 | 232.38 |
| September 21, 2023 | 241.16 |
| September 20, 2023 | 241.16 |
| September 19, 2023 | 249.15 |
| September 18, 2023 | 252.34 |
| September 15, 2023 | 266.72 |
| September 14, 2023 | 272.31 |
| September 13, 2023 | 269.91 |
| September 12, 2023 | 266.72 |
| September 11, 2023 | 280.29 |
| September 08, 2023 | 298.66 |
| September 07, 2023 | 273.11 |
| September 06, 2023 | 280.29 |
| September 05, 2023 | 308.64 |
| September 01, 2023 | 305.85 |
| August 31, 2023 | 301.86 |
| August 30, 2023 | 312.24 |
| August 29, 2023 | 311.44 |
| August 28, 2023 | 306.65 |
| August 25, 2023 | 321.02 |
| Date | Value |
|---|---|
| August 24, 2023 | 311.04 |
| August 23, 2023 | 321.82 |
| August 22, 2023 | 315.43 |
| August 21, 2023 | 317.03 |
| August 18, 2023 | 345.78 |
| August 17, 2023 | 349.77 |
| August 16, 2023 | 333.00 |
| August 15, 2023 | 330.60 |
| August 14, 2023 | 345.78 |
| August 11, 2023 | 590.93 |
| August 10, 2023 | 590.14 |
| August 09, 2023 | 594.13 |
| August 08, 2023 | 584.55 |
| August 07, 2023 | 593.33 |
| August 04, 2023 | 599.72 |
| August 03, 2023 | 616.49 |
| August 02, 2023 | 629.26 |
| August 01, 2023 | 598.92 |
| July 31, 2023 | 729.88 |
| July 28, 2023 | 765.02 |
| July 27, 2023 | 759.43 |
| July 26, 2023 | 824.91 |
| July 25, 2023 | 816.13 |
| July 24, 2023 | 874.42 |
| July 21, 2023 | 884.80 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Price to Book Value Benchmarks
| Anika Therapeutics, Inc. | 2.029 |
| Agenus, Inc. | -- |
| Amgen, Inc. | 20.22 |
| BioCryst Pharmaceuticals, Inc. | -- |
| Imunon, Inc. | 1.760 |
Price to Book Value Related Metrics
| PS Ratio | 1.999 |
| Price | 0.0739 |
| Earnings Yield | -5.72K% |
| Market Cap | 2.313M |